In2Bones Introduces CoLink® Cfx Calcaneal Fixation System

Novel Z-Plasty™ System Delivers Greater Flatfoot Surgery PrecisionMEMPHIS, Tenn.–(BUSINESS WIRE)–In2Bones Global, Inc. today announces the U.S. launch of its CoLink® Cfx Calcaneal Fixation System. This versatile collection of low-profile plates is designed to address all types of traumatic fractures

Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide

DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing more than 2 million treatments worldwide with DUROLANE, its single-injection, hyaluronic acid (HA) product used in the treatment of pain associated with osteoarthriti

Nexxt Spine LLC, Releases Stand Alone Cervical Turn Lock System

Surgeon network eager to benefit from the innovative turn lock featureSeptember 21, 2020- Noblesville, IN- Nexxt Spine LLC, a leading design and manufacturing company of spinal solutions releases the nexxt generation of their Stand Alone Cervical System with the launch of Stand Alone Cervical Turn L

THINK Surgical Unveils New Corporate Website

FREMONT, Calif., Sept. 17, 2020 /PRNewswire/ — THINK Surgical®, Inc., an advanced orthopedic robot technology company, announced the official launch of its new corporate website The website showcases the active robot included in the TSolution One® Total Knee Application.“THINK

Camber Spine Names Max Painter Global Vice President of Sales and Marketing

Spine Innovator Building ‘A-Team’ of Spinal Device Sales ProfessionalsKING OF PRUSSIA, Pa.–(BUSINESS WIRE)–Camber Spine, a leading innovator in spine and medical technologies, has named Max Painter its new Global Vice President of Sales and Marketing. Painter brings more than 20 years of sales, mark

Implanet: 2020 Half-year Results

Limited impact of the COVID-19 pandemic on the recurring operating resultUpturn in activity beginning June 2020Resumption of surgical operations seen in the 3rd quarter of 2020Implanet is holding a conference call (in French only) at 6.15 pm CEST today to present these results To join the call, plea

Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Acquisition includes lead clinical-stage compound AT-1501, a next generation anti-CD40L antibody, in development for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseasesSenior management team with extensive drug development and commercialization experience, includi